Related Experiment Video
Updated: Jun 30, 2026

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Published on: May 26, 2023
Foundation Models in Cancer Pathology: Techniques, Applications, and Future Directions
Bo Zhang1, Victor Yu Cui2, Tong Wu3
1Center of Clinical Big Data and Analytics of the Second Affiliated Hospital and the School of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
None:
Computational pathology enables scalable analysis of pathology images for cancer diagnosis and research, but conventional deep learning models remain constrained by annotation dependence and task-specific development. Recent advances in self-supervised learning, transformer-based architectures, and large-scale pretraining have given rise to computational pathology foundation models (CPathFMs), which are designed to learn transferable and reusable representations from diverse pathology data. This review first traces the development of CPathFMs by examining the data resources, backbone architectures, representation levels, input modalities, and pretraining strategies that shape their design. We then examine their applications across major cancer pathology tasks, including tumor detection, grading, and subtyping, molecular biomarker and gene expression prediction, prognostic assessment, tissue phenotyping, as well as multimodal retrieval and report generation. We further discuss key challenges that limit translation and deployment, including underrepresentation of normal tissues and benign lesions, limited generalization across domains and institutions, data overlap and benchmark contamination, task-centric evaluation and insufficiently standardized metrics, high training and infrastructure costs, and ethical concerns in model governance. Overall, CPathFMs mark an important shift from task-specific pathology artificial intelligence toward reusable representation learning. Their clinical value remains to be established through improved model performance and generalizability, more comprehensive and standardized evaluation frameworks, and prospective evidence of utility in real-world pathology workflows.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...

